Trials / Completed
CompletedNCT00591396
A Phase I Trial of ZIO-101 in Solid Tumors
A Phase I Trial of ZIO-101 in Solid Tumors: Protocol # SGL1002
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Alaunos Therapeutics · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A Phase I Trial of ZIO-101 (Darinaparsin) in Solid Tumors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZIO-101 (Darinaparsin) | Dose Escalation of ZIO-101 (Darinaparsin) given daily for five consecutive days to be repeated every 28 days for up to six months |
Timeline
- Start date
- 2005-07-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2008-01-11
- Last updated
- 2012-07-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00591396. Inclusion in this directory is not an endorsement.